Clinical Trial Update: Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and tolerability of intranasal oxytocin in patients with arginine-vasopressin deficiency, i.e., central diabetes in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Diabetes Insipidus

Drugs mentioned

• Oxytocin (intranasal) (oxytocin)

Snippet

Sponsor: Elizabeth Austen Lawson | Conditions: Vasopressin Deficiency | Phase 1 | Status: RECRUITING